Addiction is a worldwide human crisis.

In the U.S. alone, there were approximately 2.4 million opioid-dependent people in 2013, after enormous growth in the previous several years. And in a country where much progress in enlightening attitudes towards addiction has been made, only one in five opioid-dependent individuals receive buprenorphine-based treatment. Studies indicate that addiction is not just a U.S. epidemic – it’s a global crisis, with an estimated number of more than 1.3 million opioid dependents in Europe and twenty million over the rest of the planet. Too many lives are being lost. Opioid overdose is the second leading cause of accidental death in the US, claiming 16,000 lives in 2012 and an estimated 70,000 lives during the first decade of the 21st century in the EU.

And when we extend our reach to other kinds of addiction, it’s a sobering fact that 4.5% of disease and injury around the globe can be attributed to alcohol. We believe these numbers are most likely underreported, as well, and we can consider the true population that suffers from opioid and alcohol addiction to be much greater.

This must change.

Our goal is to medicalize addiction. This starts by partnering with people of influence such as healthcare professionals, policymakers, payers, and the public health community to create an environment of education and options. It starts by breaking down the social barriers so patients can be empowered to seek treatment and providing expanded access to treatments for patients all over the world.

The numbers are staggering. The need is clear. That is why we place the patient at the center of our decisions.

For further information and reference view the Indivior Prospectus.